COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Announcement of Jilin Zixin Pharmaceutical Co., Ltd. on the receipt of government subsidies from wholly-owned subsidiaries

Page view

Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2013-035

Jilin Zixin Pharmaceutical Co., Ltd.

Announcement on receipt of government subsidies from wholly-owned subsidiaries

The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.

 

According to the Jidong Development High Technology [2013] No. 757 document issued by the Development and Reform Commission of Jilin Province, the Notice of the Jilin Provincial Development and Reform Commission on the Investment Plan for the Development of Special Funds for Strategic Emerging Industries and High-Tech Industries in Jilin Province in 2013, The company's wholly-owned subsidiary Jilin Zixin Chuyuan Pharmaceutical Co., Ltd. (hereinafter referred to as: Chuyuan Pharmaceutical)'s "Ginseng Fruit and Vegetable Fermented Beverage, Ginseng Fruit and Vegetable Fermentation Chewable Tablet Project" received a subsidy of 1 million yuan. On September 25, 2013, Chuyuan Pharmaceutical received the above-mentioned subsidy of 1 million yuan from the Yanji Municipal Finance Bureau.

 

According to the relevant provisions of the “Accounting Standards for Business Enterprises”, the company recognizes the above amount as “Deferred Income”, which is expected to have no impact on the 2013 annual results. The final accounting results are subject to the audit opinion of the accounting firm, please pay attention to investors. investment risk.

 

Special announcement.

Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors

September 27, 2013